Literature DB >> 22330426

Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).

Young Kon Kim1, Min Woo Lee, Won Jae Lee, Seong Hyun Kim, Hyunchul Rhim, Jae Hoon Lim, Dongil Choi, Young-sun Kim, Kyung Mi Jang, Soon Jin Lee, Hyo Keun Lim.   

Abstract

PURPOSE: To compare the diagnostic accuracy and sensitivity of combined gadoxetic acid-enhanced magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) with each imaging approach alone for detecting small hepatic metastases (≤ 1.5 cm).
MATERIALS AND METHODS: Institutional review board approved this retrospective study and waived informed patient consent. Eighty-six patients with 179 liver metastases underwent liver MRI including unenhanced and gadoxetic acid-enhanced imaging and DWI at 3.0 T. Three image sets including unenhanced images-gadoxetic acid set (early dynamic and hepatocyte phase), DWI set, and the combined set-were analyzed independently and in consensus by 2 observers for detecting liver metastases using receiver operating characteristic analysis.
RESULTS: There was a tendency toward an increased diagnostic accuracy for the combined set (mean, 0.965) compared with that for each image set alone (mean, 0.911 for gadoxetic acid set; 0.926 for DWI set). The combined set showed better sensitivity (mean, 97.47%/95.0%: values on per-lesion/per-patient basis) than each imaging set alone (mean, 90.7%/83.7% for gadoxetic acid set; 91.6%/83.0% for DWI set) (P < 0.05) on both per-lesion basis and per-patient basis. All image sets showed similar positive predictive values.
CONCLUSIONS: The combination of gadoxetic acid-enhanced MRI and DWI yielded better diagnostic accuracy and sensitivity in the detection of small liver metastasis than each magnetic resonance scan sequence alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22330426     DOI: 10.1097/RLI.0b013e31823a1495

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  33 in total

Review 1.  Diffusion-weighted imaging of pancreatic cancer.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Flavia Dal Corso; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Radiol       Date:  2015-10-28

2.  Second shot arterial phase to overcome degraded hepatic arterial phase in liver MR imaging.

Authors:  Yang Shin Park; Jongmee Lee; Jeong Woo Kim; Cheol Min Park; Chang Hee Lee
Journal:  Eur Radiol       Date:  2018-12-14       Impact factor: 5.315

3.  Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?

Authors:  Seung Soo Kim; Kyoung Doo Song; Young Kon Kim; Hee Cheol Kim; Jung Wook Huh; Young Suk Park; Joon Oh Park; Seung Tae Kim
Journal:  Eur Radiol       Date:  2016-11-04       Impact factor: 5.315

4.  The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach.

Authors:  Diana Feier; Csilla Balassy; Nina Bastati; Romana Fragner; Friedrich Wrba; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

5.  Criteria for the selective use of contrast-enhanced intra-operative ultrasound during surgery for colorectal liver metastases.

Authors:  Guido Torzilli; Florin Botea; Matteo Donadon; Matteo Cimino; Fabio Procopio; Vittorio Pedicini; Dario Poretti; Marco Montorsi
Journal:  HPB (Oxford)       Date:  2014-05-15       Impact factor: 3.647

6.  MR visible localization device for radiographic-pathologic correlation of surgical specimens.

Authors:  Sonja Kinner; Tilman B Schubert; Elisabetta A Nocerino; Shannon Hynes; Timothy J Colgan; Agnes G Loeffler; Christopher Brace; Scott B Reeder; Emily Winslow
Journal:  Magn Reson Imaging       Date:  2016-11-27       Impact factor: 2.546

7.  Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Takamichi Murakami; Shunsuke Onoe; Hiroyuki Tokue; Kentaro Shibamoto; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2014-05-28       Impact factor: 5.315

8.  Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.

Authors:  Mi Hye Yu; Jeong Min Lee; Bo Yun Hur; Tae-You Kim; Seung-Yong Jeong; Nam-Joon Yi; Kyung-Suk Suh; Joon Koo Han; Byung-Ihn Choi
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

9.  Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen.

Authors:  Marius E Mayerhoefer; Ahmed Ba-Ssalamah; Michael Weber; Markus Mitterhauser; Harald Eidherr; Wolfgang Wadsak; Markus Raderer; Siegfried Trattnig; Andreas Herneth; Georgios Karanikas
Journal:  Eur Radiol       Date:  2013-03-08       Impact factor: 5.315

Review 10.  Diffusion-weighted imaging of the liver: techniques and applications.

Authors:  Sara Lewis; Hadrien Dyvorne; Yong Cui; Bachir Taouli
Journal:  Magn Reson Imaging Clin N Am       Date:  2014-08       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.